Intrahepatic cholangiocarcinoma is an aggressive tumor usually discovered at an advanced stage. Surgical resection is the treatment of choice but less than 50% of patients may receive curative resection. In almost 70% of patients, extended hepatectomy with vascular resection and/or bile duct resection are required to achieve a negative margin. Overall 5-year survival is around 30%. Prognosis is mainly based on tumor factors such as size, number, lymph node or vascular invasion and surgical margin. The main sites of recurrence are the liver, peritoneum and lymph nodes. In patients with liver-only recurrence, re-resection should always be considered.

Intrahepatic cholangiocarcinoma is an aggressive tumor usually discovered at an advanced stage. Surgical resection is the treatment of choice but less than 50% of patients may receive curative resection. In almost 70% of patients, extended hepatectomy with vascular resection and/or bile duct resection are required to achieve a negative margin. Overall 5-year survival is around 30%. Prognosis is mainly based on tumor factors such as size, number, lymph node or vascular invasion and surgical margin. The main sites of recurrence are the liver, peritoneum and lymph nodes. In patients with liver-only recurrence, re-resection should always be considered.

Ercolani, G., Cucchetti, A., Cucchi, M., Cescon, M., Del Gaudio, M., Ravaioli, M., et al. (2015). Surgical treatment for intrahepatic cholangiocarcinoma. New York : Nova Science Publishers, Inc..

Surgical treatment for intrahepatic cholangiocarcinoma

ERCOLANI, GIORGIO;CUCCHETTI, ALESSANDRO;CUCCHI, MICHELE;CESCON, MATTEO;DEL GAUDIO, MASSIMO;RAVAIOLI, MATTEO;PINNA, ANTONIO DANIELE
2015

Abstract

Intrahepatic cholangiocarcinoma is an aggressive tumor usually discovered at an advanced stage. Surgical resection is the treatment of choice but less than 50% of patients may receive curative resection. In almost 70% of patients, extended hepatectomy with vascular resection and/or bile duct resection are required to achieve a negative margin. Overall 5-year survival is around 30%. Prognosis is mainly based on tumor factors such as size, number, lymph node or vascular invasion and surgical margin. The main sites of recurrence are the liver, peritoneum and lymph nodes. In patients with liver-only recurrence, re-resection should always be considered.
2015
Cholangiocarcinoma
287
297
Ercolani, G., Cucchetti, A., Cucchi, M., Cescon, M., Del Gaudio, M., Ravaioli, M., et al. (2015). Surgical treatment for intrahepatic cholangiocarcinoma. New York : Nova Science Publishers, Inc..
Ercolani, Giorgio; Cucchetti, Alessandro; Cucchi, Michele; Cescon, Matteo; Del Gaudio, Massimo; Ravaioli, Matteo; Pinna, Antonio D.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/561095
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact